| Category | Cholesterol |
| Molecular Formula | C43H71F6N5O7 |
| Molecular Weight | 884.1 |
| Shipping | Ambient temperature |
| Storage | -20°C |
Cho-Arg (trifluoroacetate salt)
Cho-Arg (trifluoroacetate salt) is a steroid-based cationic lipid that contains a cholesterol skeleton coupled to an L-arginine head group. Cho-Arg forms a complex with plasmid DNA and decreases plasmid DNA migration in an agarose-gel retardant assay at charge ratios greater than or equal to 4.
Structure of 1609010-56-1
Ordering Information
*For research and manufacturing use only. We do not sell to patients.
Fast-Track Access to Precise Molecular Weight Products
Professional Solutions for Molecular Research
cGMP Capacity
- cGMP-grade lipid manufacturing
- Scalable from milligrams to kilograms
- 20+ years expertise in lipid chemistry
- In-stock supply in the US and Europe
- Comprehensive QC testing with COA, MSD
- High-purity synthetic and natural lipids
- Covers phospholipids, sterols, and sphingolipids
- 100+ types of custom lipid modifications
- Specialized lipids for LNP delivery
- Functionalized and fluorescently labeled lipids
Popular Publications Citing BOC Sciences Products
- Specification
| Synonyms | 1609010-56-1; cholest-5-en-3-ol(3beta)-3-[6-[[(2S)-2-amino-5-[(aminoiminomethyl)amino]-1-oxopentyl]amino]hexanoate],2,2,2-trifluoroacetate(1:2); [(4S)-4-azaniumyl-5-[[6-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-oxohexyl]amino]-5-oxopentyl]-(diaminomethylidene)azanium;2,2,2-trifluoroacetate; Cho-Arg (trifluoroacetate salt) |
| IUPACName | [(4S)-4-azaniumyl-5-[[6-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-oxohexyl]amino]-5-oxopentyl]-(diaminomethylidene)azanium;2,2,2-trifluoroacetate |
| CanonicalSMILES | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)CCCCCNC(=O)C(CCC[NH+]=C(N)N)[NH3+])C)C.C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-] |
| InChI | InChI=1S/C39H69N5O3.2C2HF3O2/c1-26(2)11-9-12-27(3)31-17-18-32-30-16-15-28-25-29(19-21-38(28,4)33(30)20-22-39(31,32)5)47-35(45)14-7-6-8-23-43-36(46)34(40)13-10-24-44-37(41)42;2*3-2(4,5)1(6)7/h15,26-27,29-34H,6-14,16-25,40H2,1-5H3,(H,43,46)(H4,41,42,44);2*(H,6,7)/t27-,29+,30+,31-,32+,33+,34+,38+,39-;;/m1../s1 |
| InChIKey | JUXKTYZUYMWLSD-VFBLCMJGSA-N |
Related Products
Contact our experts today for pricing and comprehensive details on our PEG offerings.
Planning to purchase or looking for custom solutions?
Get in touch with our experts today! We'll respond within 24 hours to discuss your project needs and provide a customized quote.
You May Also Be Interested In
From custom lipid synthesis to lipid nanoparticle formulation, discover complementary services tailored to your research needs.
Gain Deeper Insights
Browse related content to gain a deeper understanding of lipid synthesis and manufacturing.
PEG and PEG Derivatives
-

Bioconjugation, Imaging
-

Cell Imaging, Tracking
-

Transfection, RNA Delivery
-

Cholesterol Precursors
-

Biotech Applications, Functional Materials
-

Metabolism, Labeling
-

Drug Delivery, Nanocarriers
-

Liposomes, Drug Delivery
-

NMR, EPR Analysis
-

Biomarker Discovery, Metabolic Profiling
Online Inquiry